Discure Formulations Private Limited
About Discure Formulations Private Limited
Data last updated:
Discure Formulations Private Limited is a private limited company based in Ludhiana, Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U52601PB2017PTC046207.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Mishra and Bablu Kumar Tiwari.
Its last annual general meeting (AGM) was held on 19 December 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at H.No.167 Shiv Puri Kakowal Road Heera Nagar Colony, Ludhiana, Punjab, India – 141001.
As per the financials filed for FY 2022, the company reported a revenue of ₹12.58 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹44,902 (net margin 3.6%) and EBITDA of ₹52,060 (EBITDA margin 4.1%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No.167 Shiv Puri Kakowal Road Heera Nagar Colony, Ludhiana, Punjab, India – 141001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Discure Formulations Private Limited
The main business activity of Discure Formulations is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Discure Formulations Private Limited FY 2022 filings available
Discure Formulations Private Limited reported revenue of ₹12.58 Lakh (up 16% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Discure Formulations Private Limited
Revenue rose 16% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 16%. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Discure Formulations Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹12.58 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹52,060 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹44,902 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Discure Formulations Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Discure Formulations are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Discure Formulations Private Limited
Discure Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SLMM Curehub Pharmacy Private Limited | ₹12.62 Lakh (FY 2025) | •••• | •••• | •••• | Ambala, Haryana, India | |
| Nisan Impex Private Limited | ₹12.61 Lakh (FY 2025) | •••• | •••• | -25.0% | •••• | Ahmedabad, Gujarat, India |
| Prepharmacist Pharmacy Private Limited | ₹12.6 Lakh (FY 2022) | •••• | •••• | -85.0% | •••• | Unnao, Uttar Pradesh, India |
| Bailor Healthcare Private Limited | ₹12.58 Lakh (FY 2020) | •••• | •••• | 270.0% | •••• | Po+Ps-Mango, Jamshedpur, Jharkhand, India |
| Vitabiotics (India ) Private Limited | ₹12.58 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | Thane, Maharashtra, India |
| Discure Formulations Private Limited this company | ₹12.58 Lakh (FY 2022) | •••• | •••• | 16.0% | •••• | Ludhiana, Punjab, India |
| Atron Healthcare Private Limited | ₹12.57 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Bhopal, Madhya Pradesh, India |
| Froh Pharmaceuticals Private Limited | ₹12.57 Lakh (FY 2024) | •••• | •••• | 505.0% | •••• | Chennai, Tamil Nadu, India |
| Sarveshjee Lifecare Private Limited | ₹12.55 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Lucknow, Uttar Pradesh, India |
| Truserv Enterprises Priavte Limited | ₹12.53 Lakh (FY 2025) | •••• | •••• | 63.0% | •••• | Kolkata, West Bengal, India |
| Savitri Remedies Private Limited | ₹12.51 Lakh (FY 2022) | •••• | •••• | 1.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Discure Formulations by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Discure Formulations Private Limited
Discure Formulations Private Limited is audited by N A SIDDIQUI & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| N A SIDDIQUI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Discure Formulations Private Limited
Discure Formulations has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Mishra | Director | 07 Mar 2017 | 9 Years 7 Months | Current |
| Bablu Kumar Tiwari | Director | 27 Oct 2021 | 4 Years 11 Months | Current |
Ownership and Shareholding of Discure Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Discure Formulations Private Limited
Discure Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Discure Formulations Private Limited
Employment history and EPFO contributions of people linked to Discure Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Discure Formulations Private Limited
Discure Formulations Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Bablu Kumar Tiwari was appointed as Director on 27 Oct 2021.
Credit Ratings, Litigation & Regulatory Alerts for Discure Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Discure Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Discure Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Discure Formulations Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Discure Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Discure Formulations Private Limited
Discure Formulations is an active private limited company based in Ludhiana, Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 March 2017 (9+ years old) and is registered under CIN U52601PB2017PTC046207.
Discure Formulations reported revenue of ₹12.58 Lakh for FY 2022 (up 16% YoY).
Discure Formulations has 2 current directors:
- Amit Mishra - Director
- Bablu Kumar Tiwari - Director
Discure Formulations reported a net profit of ₹44,902 (net margin 3.6%) and EBITDA of ₹52,060 (EBITDA margin 4.1%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Discure Formulations is -16% over three years. In the latest year (FY 2022) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Discure Formulations is U52601PB2017PTC046207. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Discure Formulations was incorporated on 07 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Discure Formulations by revenue are SLMM Curehub Pharmacy Private Limited, Nisan Impex Private Limited, Prepharmacist Pharmacy Private Limited, Bailor Healthcare Private Limited, Vitabiotics (India ) Private Limited and 5 more, all in the Pharma industry (Formulations, Pharma Retail and Distribution).
Bablu Kumar Tiwari was appointed as Director on 27 Oct 2021. Pradeep Srivastava ceased to be Director on 27 Oct 2021. Neeraj Kumar Mishra ceased to be Director on 20 Mar 2018. Discure Formulations has 5 board changes on record in total.
The registered office of Discure Formulations is at H.No.167 Shiv Puri Kakowal Road Heera Nagar Colony, Ludhiana, Punjab, India – 141001.
Discure Formulations has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.